Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87,688 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.
Strober B, Sigurgeirsson B, Popp G, Sinclair R, Krell J, Stonkus S, Septe M, Elewski BE, Gottlieb AB, Zhao Y, Tran MH, Karpov A, McLeod LD, Mordin M, Papavassilis C, Nyirady J, Lebwohl M. Strober B, et al. Among authors: zhao y. Int J Dermatol. 2016 Apr;55(4):401-7. doi: 10.1111/ijd.13236. Epub 2016 Feb 11. Int J Dermatol. 2016. PMID: 26866518 Clinical Trial.
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.
Puig L, Augustin M, Blauvelt A, Gottlieb AB, Vender R, Korman NJ, Thaçi D, Zhao Y, Gilloteau I, Sherif B, Williams N, Guana A, Lebwohl MG. Puig L, et al. Among authors: zhao y. J Am Acad Dermatol. 2018 Apr;78(4):741-748. doi: 10.1016/j.jaad.2017.10.025. Epub 2017 Oct 21. J Am Acad Dermatol. 2018. PMID: 29066271 Clinical Trial.
Evaluating the economic burden of psoriasis in the United States.
Vanderpuye-Orgle J, Zhao Y, Lu J, Shrestha A, Sexton A, Seabury S, Lebwohl M. Vanderpuye-Orgle J, et al. Among authors: zhao y. J Am Acad Dermatol. 2015 Jun;72(6):961-7.e5. doi: 10.1016/j.jaad.2015.02.1099. Epub 2015 Apr 14. J Am Acad Dermatol. 2015. PMID: 25882886 Review.
Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis.
Korman NJ, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Nyirady J, Williams N, Mordin M, Tyring S. Korman NJ, et al. Among authors: zhao y. J Dermatolog Treat. 2017 Aug;28(5):384-389. doi: 10.1080/09546634.2016.1255306. Epub 2016 Nov 21. J Dermatolog Treat. 2017. PMID: 27832717 Free article. Clinical Trial.
87,688 results
You have reached the last available page of results. Please see the User Guide for more information.